AVP backs Basetwo

Basetwo , an AI platform for manufacturing engineers, raised $11.5 million in Series A funding.

The round was led by AVP, with participation from Glasswing Ventures, Deloitte Ventures, Global Brain Ventures, Shimadzu Corporation, Chiyoda Corporation, and UAE angel investors via Qora71. The company plans to use the funds to expand its platform for pharmaceutical and chemical manufacturers.

Founded in 2022, Basetwo’s Physics AI platform combines chemical engineering principles with AI to optimize pharmaceutical and chemical manufacturing. It enables virtual experiments and process simulations, reducing costs and risks associated with live testing. The company reports up to 40% improvements in cycle times and raw material usage, along with a 25% increase in product quality.

“Amid the excitement around generative AI, most applications have focused on consumer use cases using black box models that learn from data patterns and correlation rather than foundational knowledge and principles. Manufacturing requires a fundamentally different approach, incorporating decades of engineering expertise and physics-based understanding of how chemicals and equipment interact. Our Physics AI platform enables manufacturers to optimize complex processes with powerful and explainable models. The confidence of our investors in this Series A round is a testament to the transformative potential of our approach. We’re thrilled to have their support as we expand our capabilities and continue to empower manufacturers with cutting-edge solutions for the challenges of today and tomorrow.” – Thouheed Abdul Gaffoor, CEO and Co-founder of Basetwo.

The funding will support the development of Basetwo’s AutoPilot technology for real-time manufacturing control and aid its expansion in the US, Japan, Europe, and the Middle East.